EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer

In cancer patients, thrombocytopenia can result from bone marrow infiltration or from anticancer medications and represents an important limitation for the use of antithrombotic treatments, including anticoagulant, antiplatelet, and fibrinolytic agents. These drugs are often required for prevention...

Descripción completa

Detalles Bibliográficos
Autores principales: Falanga, Anna, Leader, Avi, Ambaglio, Chiara, Bagoly, Zsuzsa, Castaman, Giancarlo, Elalamy, Ismail, Lecumberri, Ramon, Niessner, Alexander, Pabinger, Ingrid, Szmit, Sebastian, Trinchero, Alice, Ten Cate, Hugo, Rocca, Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Guideline Article – Consensus based
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281983/
https://www.ncbi.nlm.nih.gov/pubmed/35924068
http://dx.doi.org/10.1097/HS9.0000000000000750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281983/
https://www.ncbi.nlm.nih.gov/pubmed/35924068
http://dx.doi.org/10.1097/HS9.0000000000000750

Ejemplares similares